The ROE as of December 2024 (TTM) for Verve Therapeutics, Inc. (VERV) is -35.23%

According to Verve Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -35.23%. This represents a change of 298.02% compared to the average of -8.85% of the last 4 quarters.

Verve Therapeutics, Inc. (VERV) Historical ROE (quarterly & annually)

How has VERV ROE performed in the past?

The mean historical ROE of Verve Therapeutics, Inc. over the last ten years is 14.68%. The current -35.23% ROE has changed -340.00% with respect to the historical average. Over the past ten years (40 quarters), VERV's ROE was at its highest in in the December 2020 quarter at 36.82%. The ROE was at its lowest in in the March 2020 quarter at -94.53%.

Verve Therapeutics, Inc. (VERV) ROE by Quarter and Year

Discovering the peaks and valleys of Verve Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Verve Therapeutics, Inc. (VERV) Average ROE

How has VERV ROE performed in the past?

The current ROE of Verve Therapeutics, Inc. (VERV) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Verve Therapeutics, Inc. (VERV) ROE vs. Peers

How is VERV’s ROE compared to its peers?

Verve Therapeutics, Inc.’s ROE is greater than Adaptive Biotechnologies Corporation (-74.47%), greater than Beam Therapeutics Inc. (-16.22%), greater than Caribou Biosciences, Inc. (-45.46%), greater than Sana Biotechnology, Inc. (-94.47%), greater than Intellia Therapeutics, Inc. (-51.97%), greater than Editas Medicine, Inc. (-80.13%), greater than CRISPR Therapeutics AG (-12.15%), greater than Prime Medicine, Inc. (-114.95%), greater than Theseus Pharmaceuticals, Inc. (-12.35%), greater than aTyr Pharma, Inc. (-56.83%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Century Therapeutics, Inc. (-66.58%), greater than Blueprint Medicines Corporation (-47.66%),

Build a custom stock screener for Verve Therapeutics, Inc. (VERV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verve Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verve Therapeutics, Inc. (VERV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verve Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.